EC workshop on pharmaceutical/device borderline issues:
This article was originally published in Clinica
The European Commission is to hold a workshop on October 28 on the overlap between the pharmaceutical directives and other directives covering products that are on its borderline, including medical devices. This is a key issue for manufacturers of drug/device combination products, and products on the drug/device borderline who are still unclear to what extent the new pharmaceutical directive will have supremacy over medical device regulations.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.